Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

227Th-EDTMP: a potential therapeutic agent for bone metastasis.

Kohshin Washiyama1, Ryohei Amano, Jun Sasaki

  • 1School of Health Sciences, Faculty of Medicine, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 920-0942, Japan. kwashi@mhs.mp.kanazawa-u.ac.jp

Nuclear Medicine and Biology
|October 7, 2004
PubMed
Summary

227Th-EDTMP demonstrates significant bone uptake and retention, with rapid clearance from other tissues. Its daughter nuclide, 223Ra, also shows high bone retention, indicating potential for treating bone metastasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidental Malignancies in the Emergency Department: Missed Diagnoses, Radiological Difficulty, and a Risk-Based Framework for Follow-Up.

Journal of clinical medicine·2026
Same author

Diagnostic Stewardship to Optimize Blood Culture in a Pediatric Cardiac Intensive Care Unit.

Pediatric quality & safety·2026
Same author

Magnetic Resonance Imaging Classification Using the Three-Dimensional T2-weighted SPACE Method for Brachial Plexus Injury.

The Journal of hand surgery·2026
Same author

Analysis of immune-related alterations in blood and spinal cord of canine degenerative myelopathy, a spontaneous model of amyotrophic lateral sclerosis.

Scientific reports·2026
Same author

Sex and Age Differences in Outcomes of Traumatic Brain Injury: Findings from the Japan Neurotrauma Data Bank.

Journal of clinical medicine·2026
Same author

Cost-effective ecological monitoring in shallow waters using amphibious unmanned aerial vehicles (AUAV) and deep learning-based computer vision.

Marine environmental research·2026

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Oncology

Background:

  • Bone metastasis is a common complication of various cancers, significantly impacting patient prognosis and quality of life.
  • Targeted radiopharmaceuticals offer a promising approach for localized treatment of bone metastases.
  • Understanding the biodistribution and retention of novel radiotracers is crucial for their clinical development.

Purpose of the Study:

  • To evaluate the biodistribution and bone retention of 227Th-EDTMP.
  • To assess the retention of its daughter nuclide, 223Ra, in bone tissue.
  • To determine the potential of 227Th-EDTMP as a therapeutic agent for bone metastasis.

Main Methods:

  • Biodistribution studies of 227Th-EDTMP in preclinical models.

Related Experiment Videos

  • Quantification of 227Th-EDTMP uptake and clearance in blood, soft tissues, and bone.
  • Measurement of 223Ra retention in bone at various time points post-injection.

    • Main Results:

    • 227Th-EDTMP exhibited high uptake and prolonged retention specifically in bone tissue.
    • Rapid clearance of 227Th-EDTMP from blood and soft tissues was observed, with femur-to-tissue ratios exceeding 100 within 30 minutes (excluding kidneys).
    • High retention indices for 223Ra in bone were noted at 7 and 14 days, with no significant differences between these time points.

    Conclusions:

    • 227Th-EDTMP shows favorable biodistribution characteristics for targeting bone.
    • The sustained retention of 223Ra in bone supports its potential therapeutic efficacy.
    • 227Th-EDTMP is a promising radiotherapeutic candidate for managing bone metastasis.